Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

c-Kit Expression in Patients with Uterine Leiomyosarcomas

15 May 2004

Abstract excerpt

PURPOSE: Uterine leiomyosarcomas are rare tumors characterized by their resistance to chemotherapy and radiation treatment. Surgery is the primary method of treatment, but for patients with unresectable disease, alternate therapeutic options are clearly warranted. According to initial observations of c-KIT expression, correlation with a bad prognosis, and the successful therapeutic possibility of STI571 in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastrointestinal Tumor Research and Treatment
Share to Sarcoma Diagnosis and Treatment
Share to Uterine Myomas and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15161707
DOI: 10.1158/1078-0432.ccr-03-0363

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

c-Kit Expression in Patients with Uterine LeiomyosarcomasPMID 15161707Read ↗

C-kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus.Semantic proximity Read ↗

Predicting the antitumor effects of STI571 by analysis of c-kit gene mutations in gastrointestinal stromal tumors of the stomach: Report of a case.Semantic proximity Read ↗

KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations.Semantic proximity Read ↗

A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation.Semantic proximity Read ↗

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications.Semantic proximity Read ↗

Immunohistochemical evaluation of KIT expression in sarcomas of the gynecologic region.Semantic proximity Read ↗

Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.Semantic proximity Read ↗

STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1.Semantic proximity Read ↗

Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens.Semantic proximity Read ↗

Mutations in exon 11 of the c-kit gene in a myogenic tumor and a neurogenic tumor as well as in gastrointestinal stromal tumors. Utility of c-kit mutation as a prognostic biomarker for gastrointestinal mesenchymal tumor.Semantic proximity Read ↗

Low frequency of somatic mutations in uterine sarcomas: a molecular analysis and review of the literature.Semantic proximity Read ↗

Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasmsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.